REN ENANTIOMER AV EN METASUBSTITUERAD 3-FENYL-1-PROPYLPIPERIDIN
The pure enantiomeric form of a compound of the formula wherein Y is OH, R COO, R R NCOO- or R O whereby R is an aliphatic hydrocarbon residue having 1-17 carbon atoms, a phenyl, 2,6-dimethylphenyl or 3- or 4-hydroxyphenyl group or a 3- or 4-alkanoyloxyphenyl group with the formula wherein R is an a...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | swe |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The pure enantiomeric form of a compound of the formula wherein Y is OH, R COO, R R NCOO- or R O whereby R is an aliphatic hydrocarbon residue having 1-17 carbon atoms, a phenyl, 2,6-dimethylphenyl or 3- or 4-hydroxyphenyl group or a 3- or 4-alkanoyloxyphenyl group with the formula wherein R is an alkyl group having 1-6 carbon atoms, or R is a group wherein R is hydrogen, an alkyl group having 1 to 5 carbon atoms or a phenyl group, R is hydrogen, an alkyl group having 1 to 5 carbon atoms or an acyl group and R is hydrogen or an alkyl group having 1 to 5 carbon atoms, R is hydrogen, an alkyl group having 1-5 carbon atoms, a phenethyl, benzyl or phenyl group which may be mono- or disubstituted in the aromatic part with a methyl, methoxy, hydroxy, nitro or cyano group or a halogen, R is H, an alkyl group having 1 to 5 carbon atoms or a phenyl group, or R and R together with the nitrogen atom form a 5, 6 or 7 membered ring that may contain 1 to 3 double bonds and/or 1 or 2 further heteroatoms selected frm N, O and S, and R is an allyl or benzyl group, said enantiomer having the same absolute configuration at the asymmetric carbon atom as that of the (-)-enantiomer of the compound of formula I wherein Y is OH, as bases and pharmaceutically acceptable acid additiion salts thereof, processes for their preparation and pharmaceutical preparations and methods of treatment employing such compounds. The compounds are useful for treatment of disorders in the central nervous system. |
---|